Filing Details
- Accession Number:
- 0001354488-17-000517
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-17 16:08:36
- Reporting Period:
- 2017-05-15
- Filing Date:
- 2017-05-17
- Accepted Time:
- 2017-05-17 16:08:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1410098 | Cormedix Inc. | CRMD | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1672645 | Myron Kaplan | C/O Cormedix Inc. 1430 U.s. Highway 206, Suite 200 Bedminster NJ 07921 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-15 | 30,000 | $0.49 | 50,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy Common Stock) | $2.24 | 2027-02-21 | 40,000 | 40,000 | Direct | |
| Common Stock | Restricted Stock Units | $0.00 | 10,000 | 10,000 | Direct | ||
| Common Stock | Stock Option (Right to Buy Common Stock) | $4.28 | 2026-04-28 | 50,000 | 50,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2027-02-21 | 40,000 | 40,000 | Direct |
| 10,000 | 10,000 | Direct | |
| 2026-04-28 | 50,000 | 50,000 | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $0.472 to $0.500. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- The options shall vest as follows: 1/3 on 4/28/2016, 1/3 on 4/28/2017, and 1/3 on 4/28/2018.
Billionaire Hedge Funds
